SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-057738
Filing Date
2018-11-08
Accepted
2018-11-08 16:07:07
Documents
2
Period of Report
2014-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3194
2 POA DOCUMENT poa.txt EX-24.4A_816266 2206
  Complete submission text file 0001209191-18-057738.txt   6859
Mailing Address C/O ALEXANDRIA REAL ESTATE EQUITIES, INC 385 E. COLORADO BLVD. SUITE 299 PASADENA CA 91101
Business Address
MARCUS JOEL S (Reporting) CIK: 0001216955 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36548 | Film No.: 181169717

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)